The Surgical Wound Care Associates model uses cutting-edge biologic therapies and fundamental approaches to complex, chronic, and postoperative wound healing. Failure to adopt an effective wound care continuum creates exposure to regulatory penalties, increased costs, and most importantly, decreased quality of patient care. There is increasing regulatory attention to chronic wound care. This model delivers highly effective clinical results across the spectrum of patient and provider education, aggressive intervention utilizing state-of-the-art therapies, identification and treatment of underlying disease, and coordination of care for at-risk patients.